They were randomised in a 2:1 ratio to receive either mifepristone (300–900 mg daily) or placebo for 24 weeks. Randomisation ...

HHS Secretary Robert F. Kennedy Jr. asked the FDA "to review the latest data on mifepristone​," but experts say concerns ...

An open letter signed by more than 50 industry executives blasts a “fundamentally, fatally flawed” report that urges greater ...

A North Texas man charged with capital murder after slipping mifepristone into his girlfriend’s food signals another attempt ...

Emergency contraceptives and medical abortion drugs have all but disappeared from Russian pharmacy shelves after authorities ...

"This is potentially paradigm-shifting data," Buse previously told MedPage Today, adding that the investigators were "shocked ...

Researchers have discovered in a randomized placebo-controlled trial that mifepristone (Korlym) led to a significant ...

A group of 53 biotech leaders are expressing their support for mifepristone in a letter to the Food and Drug Administration, urging the agency not to impose new restrictions on its use as an abortion ...

The move follows an announcement by Secretary Robert F. Kennedy Jr. that the FDA will be conducting a review of mifepristone.

Pro-choice advocates say the science is settled on the abortion pill mifepristone, but critics argue that better safeguards need to be in place after the FDA relaxed them in recent years.

FDA Commissioner Marty Makary’s pledge to reexamine the safety of medication abortion isn’t just pointless — it’s dangerous.

In patients with hypercortisolism and inadequately controlled type 2 diabetes, mifepristone lowered HbA1c levels by about 1.5 ...